Showing results (531-540 of 1,278) with videos related to
Sort By:
Pageof 128
Neuroscience|November 16, 2010
Recovery of motor performance deterioration induced by a demanding finger motor task does not follow cortical excitability dynamicsL Avanzino, A Tacchino, G Abbruzzese, et al.Carcinogenesis|February 23, 2019
Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancerYun Feng, Hongliang Liu, Bensong Duan, et al.Transfusion Medicine (Oxford, England)|February 17, 2005
Pre-storage leucocyte depletion and transfusion reaction rates in cancer patientsA Da Ponte, E Bidoli, R Talamini, et al.Nature Protocols|October 31, 2009
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceMichael P Kim, Douglas B Evans, Huamin Wang, et al.British Journal of Cancer|November 26, 2009
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestineM J Overman, J Pozadzides, S Kopetz, et al.Journal of Biological Regulators and Homeostatic Agents|December 6, 2017
Hyaluronan: an overviewF Abbruzzese, F Basoli, M Costantini, et al.International Journal of Surgical Investigation|May 31, 2003
Symptomatic and asymptomatic carotid artery lesions in peripheral vascular disease: a prospective studyE Ballotta, G Da Giau, L Renon, et al.British Journal of Cancer|July 7, 2005
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancerA H Ko, J Hwang, A P Venook, et al.Cancer Detection and Prevention|October 28, 2006
Pancreatic cancer mortality in Egypt: comparison to the United States pancreatic cancer mortality ratesAmr S Soliman, Qing Zhang, Thanaa Saleh, et al.American Journal of Clinical Oncology|December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinomaD F Moore, R Pazdur, S Sugarman, et al.Pageof 128